IL10 and metabolic dysfunction-associated steatotic liver disease: Several studies have found an association between NAFLD severity and serum IL-10 levels reduction, suggesting the involvement of IL-10 in immune regulation in the liver (den Boer et al., 2006; Paredes-Turrubiarte et al., 2016).